Leiden Jeffrey M
- SEC CIK
- 0001242825
In the past year, 1 open-market purchase filing worth $100.0K and 2 sale filings worth $60.9M.
Current role at each company
- ODTX Odyssey Therapeutics, Inc.Directoras of May 11, 2026
- VRTX Vertex Pharmaceuticals IncExecutive Chairmanas of Feb 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $100.0K
- 1 filing
- Sold
- $60.9M
- 2 filings
- Net
- −$60.8M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Leiden Jeffrey M as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
ODTX Odyssey Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 (view filing) | May 8 | 3 days | Leiden Jeffrey MDirector | PPurchase | +5.00K | $20.00 | +$100.0K | +1.9%270.2K after |
VRTX Vertex Pharmaceuticals Inc
Executive Chairman12 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 (view filing) | Apr 13 | 1 day | Leiden Jeffrey MExecutive Chairman | SSale | −15.8K | $289.04 | −$4.56M | −17.6%74.2K after | |
| Jul 27, 2022 (view filing) | Jul 25 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −132.1K | $281.38 | −$37.2M | −98.2%2.42K after | 5 lots |
| May 4, 2023 (view filing) | May 2-3 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −11.0K | $349.98 | −$3.84M | −22.7%37.4K after | 6 lots10b5-1 |
| May 9, 2023 (view filing) | May 5-8 | 4 days | Leiden Jeffrey MExecutive Chairman | SSale | −2.00K | $349.25 | −$699.9K | −5.4%35.4K after | 3 lots10b5-1 |
| Oct 18, 2023 (view filing) | Oct 16 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −13.0K | $374.00 | −$4.85M | −36.6%22.4K after | 10b5-1 |
| Dec 15, 2023 (view filing) | Dec 13 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −13.4K | $399.42 | −$5.33M | −59.5%9.07K after | 2 lots10b5-1 |
| Jan 10, 2024 (view filing) | Jan 8 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −6.65K | $419.07 | −$2.79M | −73.3%2.42K after | 10b5-1 |
| Feb 14, 2024 (view filing) | Feb 12-13 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −3.39K | $419.42 | −$1.42M | −11.2%26.9K after | 3 lots10b5-1 |
| Feb 16, 2024 (view filing) | Feb 14-15 | 2 days | Leiden Jeffrey MExecutive Chairman | SSale | −9.01K | $419.10 | −$3.78M | −33.5%17.9K after | 2 lots10b5-1 |
| Sep 4, 2024 (view filing) | Aug 30 | 5 days | Leiden Jeffrey MExecutive Chairman | SSale | −3.78K | $499.00 | −$1.89M | −27.5%9.99K after | 10b5-1 |